[Prevalence of dyslipidemia in middle-aged adults with NOS3 gene polymorphism and low cardiorespiratory fitness]

Arq Bras Endocrinol Metabol. 2013 Feb;57(1):33-43. doi: 10.1590/s0004-27302013000100005.
[Article in Portuguese]

Abstract

Objective: To evaluate the influence of the interaction between endothelial nitric oxide synthase gene (NOS3) polymorphisms at positions -786T>C, Glu298Asp and intron 4b/a, and cardiorespiratory fitness on plasma nitrite/nitrate levels, blood pressure, lipid profile, and prevalence of cardiometabolic disorders.

Subjects and methods: Ninety-two volunteers were genotyped for NOS3 polymorphisms at positions (-786T>C and Glu298Asp) and (intron 4b/a) and divided according to the genotype: non-polymorphic (NP) and polymorphic (P). After that, they were subdivided according to the cardiorespiratory fitness associated with genotype: high (HNP and HP) and low (LNP and LP).

Results: The subjects with polymorphism for the interactions at positions Glu298Asp + intron 4b/a, and Glu298Asp+-786T>C showed the highest values in total cholesterol, as well as dyslipidemia.

Conclusion: Our findings show that NOS3 gene polymorphisms at positions -786T>C, Glu298Asp, and intron 4b/a exert negative effects on the lipid profile compared with those who do not carry polymorphisms.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiovascular System / physiopathology
  • Cholesterol / blood
  • Dyslipidemias / blood
  • Dyslipidemias / epidemiology
  • Dyslipidemias / genetics*
  • Epidemiologic Methods
  • Female
  • Genotype
  • Glutamic Acid / genetics
  • Humans
  • Introns / genetics
  • Male
  • Middle Aged
  • Nitrates / blood
  • Nitric Oxide Synthase Type III / genetics*
  • Nitrites / blood
  • Oxygen Consumption / genetics
  • Polymorphism, Genetic / genetics*
  • Promoter Regions, Genetic / genetics
  • Respiratory System / physiopathology

Substances

  • Nitrates
  • Nitrites
  • Glutamic Acid
  • Cholesterol
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III